NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) has 7 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $67K, and 1 sales totalling $32K. Most recent filing: Sept. 8, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 8, 2026 filed Aug. 27, 2026 | Wambeke David J. Chief Business Officer | +$66,999 | 68,333 | +2000% | No | |
|
|
||||||
| Aug. 28, 2026 | Johns Emily J. Chief Administrative Officer | $0 | 12,500 | 0% | No | |
|
|
||||||
| Aug. 28, 2026 | Volker Christopher Chief Financial Officer | $0 | 35,000 | 0% | No | |
|
|
||||||
| Aug. 28, 2026 | Christianson Mark Market Development Director | $0 | 12,500 | 0% | No | |
|
|
||||||
| Aug. 28, 2026 | Mertens Steve Chief Technology Officer | $0 | 15,000 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 7 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free